Form D · Biotechnology

Orasi Medical Inc

Minneapolis, MN · CIK 0001416249

Offering snapshot reported Nov 16, 2010 · SEC filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Nov 16, 2010	Initial	$1,769,376	No comparison	16	SEC filing
Jun 18, 2009	Initial	$52,500	No comparison	1	SEC filing
Apr 28, 2009	Initial	$3,510,126	No comparison	Not reported	SEC filing
Oct 23, 2007	Paper	Not reported	No comparison	Not reported	SEC filing

The minimum in this offering is $700,000

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
John Christopher Feltl	2366353	Feltl and Company · CRD 6905

Source: Form D, filed Nov 16, 2010. Minimum accepted may differ from a standard advertised minimum.

No confirmed ADV fund connection is available for this issuer.

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Michael Cassano	Executive
H. Christian Fibiger	Director
Sarah Haecker	Executive
Kenneth Heithoff	Director
Michael Jerstad	Director
Douglas Johnson	Director
Steven Lebow	Executive
Shawn Lyndon	Director, Executive, Promoter
Rick Pauls	Director
Dallas Steiner	Executive
Todd Verdoorn	Executive
Mark Wagner	Director, Promoter

Address:

6465 Wayzata Boulevard, Suite 810
Minneapolis, MN, 55426